H. Dreja

发表

CD4 binding site broadly neutralizing antibody selection of HIV-1 escape mutants.

Lei Chen, C. Pade, Á. McKnight, 2015, The Journal of general virology.

Effects of virion surface gp120 density on infection by HIV-1 and viral production by infected cells.

M. Piechaczyk, V. Pinet, Yea-Lih Lin, 2005, Virology.

Monoclonal Antibody 667 Recognizes the Variable Region A Motif of the Ecotropic Retrovirus CasBrE Envelope Glycoprotein and Inhibits Env Binding to the Viral Receptor

C. Granier, L. Gros, M. Piechaczyk, 2003, Journal of Virology.

Induction of Long-Term Protective Antiviral Endogenous Immune Response by Short Neutralizing Monoclonal Antibody Treatment

L. Gros, M. Piechaczyk, M. Pelegrin, 2005, Journal of Virology.

Accessing of recombinant human monoclonal antibodies from patient libraries by eukaryotic ribosome display.

Angray S. Kang, S. Jeffs, Á. McKnight, 2012, Human antibodies.

Interferon-β Gene Therapy for the Treatment of Arthritis

Y. Chernajovsky, D. Gould, K. Triantaphyllopoulos, 2003 .

Lower frequency of apolipoprotein E4 allele in an “elderly” Down's syndrome population

B. Lawlor, Z. Hawi, J. Tyrrell, 1996, Biological Psychiatry.

The effects of N-terminal insertion into VSV-G of an scFv peptide

M. Piechaczyk, H. Dreja, 2006, Virology Journal.

Large-scale use of knockout validation to confirm antibody specificity

M. Sassi, G. de Block, Julia Lochead, 2018, The Journal of Immunology.

Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals

Q. Sattentau, D. Montefiori, W. Weissenhorn, 2010, PloS one.

A novel doxycycline inducible autoregulatory plasmid which displays ‘on’/‘off’ regulation suited to gene therapy applications

Y. Chernajovsky, F. Ledda, H. Dreja, 2000, Gene Therapy.

The Cell Adhesion Molecule “CAR” and Sialic Acid on Human Erythrocytes Influence Adenovirus In Vivo Biodistribution

O. Billet, S. Cusack, G. Schoehn, 2009, PLoS pathogens.

A whole genome screen for HIV restriction factors

Áine McKnight, D. Beach, M. Dittmar, 2011, Retrovirology.

Soluble complement receptor 1 (CD35) delivered by retrovirally infected syngeneic cells or by naked DNA injection prevents the progression of collagen-induced arthritis.

A. Annenkov, Y. Chernajovsky, H. Dreja, 2000, Arthritis and rheumatism.

A Fusion Intermediate gp41 Immunogen Elicits Neutralizing Antibodies to HIV-1*

D. Montefiori, W. Weissenhorn, J. Heeney, 2014, The Journal of Biological Chemistry.

Gene Therapy for Rheumatoid Arthritis

O. Podhajcer, D. Baker, A. Annenkov, 1998, Drugs & aging.

Neutralization activity in a geographically diverse East London cohort of human immunodeficiency virus type 1-infected patients: clade C infection results in a stronger and broader humoral immune response than clade B infection.

D. Montefiori, C. Orkin, H. Gao, 2010, The Journal of general virology.

Immuno- and genetic therapy in autoimmune diseases

A. Annenkov, Y. Chernajovsky, R. Mageed, 2000, Genes and Immunity.

Recombinant Galectin-1 and Its Genetic Delivery Suppress Collagen-Induced Arthritis via T Cell Apoptosis

G. Rabinovich, J. Hirabayashi, Y. Chernajovsky, 1999, The Journal of experimental medicine.

Targeting cytokines to inflammation sites

Yuti Chernajovsky, Y. Chernajovsky, Gill Adams, 2003, Nature Biotechnology.

Elicits Neutralizing Antibodies to HIV-1 A Fusion Intermediate gp 41 Immunogen Microbiology

Ralf, Jens, W. Weissenhorn, 2014 .

Knockout validation of antibodies to Ki67: a marker for cellular proliferation

L. Parton, Julia Lochead, H. Dreja, 2017, Journal of Immunology.

Monoclonal Antibody 667 Recognizes the Variable Region A Motif of the Ecotropic Retrovirus CasBrE Envelope Glycoprotein and Inhibits Env Binding to the Viral Receptor

C. Granier, L. Gros, M. Piechaczyk, 2003, Journal of Virology.

CD4 binding site broadly neutralizing antibody selection of HIV-1 escape mutants.

Lei Chen, C. Pade, Á. McKnight, 2015, The Journal of general virology.